Skip to main content

Day: April 14, 2022

Nexstim Plc: Managers’ Transactions, Hildén

Company Announcement, Helsinki, 14 April 2022 at 3:00 PM (EEST) Nexstim Plc: Managers’ Transactions, Hildén Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”) announces managers’ transactions as follows: Person subject to the notification requirementName: Timo HildénPosition: Member of the Board/Deputy member Issuer: Nexstim OyjLEI: 743700S7ZI0LNMHZ6Y27Notification type: INITIAL NOTIFICATIONReference number: 13303/7/6____________________________________________ Transaction date: 2022-04-13Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)Instrument type: SHAREISIN: FI4000506811Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE(X) Linked to stock option programme Transaction details(1): Volume: 1512 Unit price: 0 EURAggregated transactions(1): Volume: 1512 Volume weighted average price: 0 EUR Further...

Continue reading

Otonomo Completes Acquisition of The Floow

HERZLIYA, Israel and SAN FRANCISCO, April 14, 2022 (GLOBE NEWSWIRE) — Otonomo Technologies Ltd. (Nasdaq:OTMO) (“Otonomo”), the mobility intelligence company, today announced that it has completed its previously disclosed acquisition of The Floow, a United Kingdom-based SaaS provider of connected insurance technology for major carriers globally. As a part of the agreement, Otonomo welcomes Founder and CEO of The Floow, Aldo Monteforte, to the management team where he will continue to lead The Floow on its growth path. “We are pleased to announce the successful closing of the acquisition and we look forward to benefiting from the complementary set of insurance data solutions, customers and markets that The Floow brings,” said Ben Volkow, Chief Executive Officer. “By combining The Floow’s established portfolio of connected insurance...

Continue reading

BeyondSpring Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update

– Company to host call today, April 14, 2022 at 8:00 am ET – Conference call can be accessed by dialing 877-451-6152 (U.S. and Canada) or +1-201-389-0879 (International). The passcode is 13728822. The live webcast can be accessed here or by visiting the “investors” section of the BeyondSpring website NEW YORK, April 14, 2022 (GLOBE NEWSWIRE) — BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a clinical stage global biopharmaceutical company focused on developing innovative cancer therapies to improve clinical outcomes for patients who have high unmet medical needs, today announced its financial results for the fourth quarter and year ended December 31, 2021 and provided a corporate update. At the start of 2022, the Company took steps to streamline its operations and is focused on executing on near-term...

Continue reading

BurgerFi Reports Fourth Quarter and Full Year 2021 Results

Revenue Grows 261% to $35.1 million in Fourth Quarter; Systemwide same store sales increases of 7% Revenue Grows 103% in 2021; Systemwide same store sales increase 14% and New Unit Growth of 13% Conference Call today, April 14, at 8:30 a.m. ET FORT LAUDERDALE, Fla., April 14, 2022 (GLOBE NEWSWIRE) — BurgerFi International, Inc. (Nasdaq: BFI, BFIIW) (“BurgerFi” or the “Company”), owner of one of the nation’s leading fast-casual “better burger” dining concepts through the BurgerFi brand, and the high-quality, casual dining pizza brand under the name Anthony’s Coal Fired Pizza & Wings (“Anthony’s”), today reported financial results for the fourth quarter and full year ended December 31, 2021. Fourth Quarter and Full Year 2021 Key Metrics1 Summary  BurgerFi Brand Only(in thousands, except for percentage data) Three MonthsEndedDecember...

Continue reading

Guardian Capital Announces April 2022 Distributions for Guardian Capital ETFs

TORONTO, April 14, 2022 (GLOBE NEWSWIRE) — Guardian Capital LP announces the following regular cash distributions for the period ending April 30, 2022, in respect of the Guardian Capital ETFs listed below. In each case, the distribution will be paid on April 29, 2022 to unitholders of record on April 25, 2022. The ex-dividend date in each case is April 22, 2022.  Exchange Traded Fund Series of ETF Units DistributionFrequency TradingSymbol Distribution Amount(per ETF Unit)Guardian Directed Equity Path ETF Hedged Monthly GDEP $0.0746Guardian Directed Equity Path ETF Unhedged Monthly GDEP.B $0.0684Guardian Directed Premium Yield ETF Hedged Monthly GDPY $0.1231Guardian Directed Premium Yield ETF Unhedged Monthly GDPY.B $0.1133About Guardian Capital LPGuardian Capital LP is the manager and portfolio manager of the...

Continue reading

Nexstim Plc: Managers’ Transactions, Niemistö

Company Announcement, Helsinki, 14 April 2022 at 2:30 PM (EEST) Nexstim Plc: Managers’ Transactions, Niemistö Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”) announces managers’ transactions as follows: Person subject to the notification requirementName: Leena NiemistöPosition: Member of the Board/Deputy member Issuer: Nexstim OyjLEI: 743700S7ZI0LNMHZ6Y27Notification type: INITIAL NOTIFICATIONReference number: 13299/7/8____________________________________________ Transaction date: 2022-04-13Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)Instrument type: SHAREISIN: FI4000506811Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE(X) Linked to stock option programme Transaction details(1): Volume: 1867 Unit price: 0 EURAggregated transactions(1): Volume: 1867 Volume weighted average price: 0 EUR____________________________________________ Transaction...

Continue reading

Provectus Biopharmaceuticals Names Aru Narendran, MD, PhD to Scientific Advisory Board

KNOXVILLE, TN, April 14, 2022 (GLOBE NEWSWIRE) — Provectus (OTCQB: PVCT) today announced the addition of Aru Narendran, MD, PhD to the Company’s Scientific Advisory Board. Dr. Narendran is a professor in the departments of Pediatrics, Oncology, and Biochemistry & Molecular Biology at the University of Calgary’s Cumming School of Medicine (Calgary, Alberta, Canada), and holds the Kids Cancer Care Foundation Endowed Chair in Clinical and Translational Research in pediatric oncology. Over the last five years, Provectus’ collaboration with Dr. Narendran and his lab research team at the University of Calgary has yielded:Preclinical exploration of rose bengal sodium (RBS) – the Company’s proprietary small molecule halogenated xanthene – for the treatments of pediatric oncology (neuroblastoma, Ewing sarcoma, rhabdomyosarcoma, and...

Continue reading

Purpose Investments Inc. Announces Risk Rating Changes

TORONTO, April 14, 2022 (GLOBE NEWSWIRE) — Purpose Investments Inc. (“Purpose Investments”) today announced changes to the risk rating of four of its funds effective immediately. These changes are the result of the implementation of the standardized risk classification methodology pursuant to National Instrument 81-102 – Investment Funds and are not a result of any changes to the investment objectives, strategies or management of the funds.Fund Current NewPurpose Tactical Hedged Equity Fund medium low to mediumPurpose Monthly Income Fund low low to mediumPurpose Canadian Preferred Share Fund low to medium mediumPurpose Multi-Asset Income Fund low low to mediumPlease consult your advisor and read the simplified prospectus or ETF facts of the applicable fund before investing. About Purpose Investments Inc. Purpose...

Continue reading

Agile Therapeutics Announces First Quarter 2022 Prescription Data for Twirla®

29% increase in Twirla cycles27% increase in total prescriptions (TRx) of Twirla PRINCETON, N.J., April 14, 2022 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced Twirla prescription data for the first quarter 2022. During the first quarter 2022:Twirla cycles dispensed increased 29% to 16,602 Total prescriptions (TRx) increased 27% to 12,494 Refills (RRx) increased 31% to 7,143 New prescriptions (NRx) increased 22% to 5,351 Total prescribers increased 26% to 5,837“As I said on our recent fourth quarter 2021 earnings call, we believe we have a brand that is building steady growth momentum, which we saw continue in the prescription demand data for the first quarter 2022,” said Al Altomari, Agile Therapeutics Chairman and Chief Executive Officer. “This growth is consistent...

Continue reading

Milestone Scientific Enacts Strategy to Diversify Channel Partnerships and Announces Initiatives to Expand Dental Sales

Milestone and Keystone Dental Group Form Strategic Channel Partnershipto Expand the STA Single Tooth Anesthesia® System within Implant Dentistry Milestone Establishes Partnership with American Independent Dental Alliance,America’s Premier DSO Network of Private Practice Dentists Enters into Agreement with Esthetic Professionals to Enhance Educational Activities ROSELAND, N.J., April 14, 2022 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide virtually painless and precise injections, today announced it has expanded its dental strategy, entering the growing dental implant and dental service organization (DSO) markets, along with new educational initiatives. Recent Agreements:Added Keystone Dental Group as a strategic channel partner for the STA...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.